Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M700111200 on July 23, 2007

J. Biol. Chem., Vol. 282, Issue 40, 29130-29143, October 5, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/40/29130    most recent
M700111200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Payne, H. L.
Right arrow Articles by Thompson, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Payne, H. L.
Right arrow Articles by Thompson, C. L.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

GABAA {alpha}6-Containing Receptors Are Selectively Compromised in Cerebellar Granule Cells of the Ataxic Mouse, Stargazer*

Helen L. Payne{ddagger}12, William M. Connelly§13, Jane H. Ives{ddagger}, Reinhard Lehner||4, Birgit Furtmuller||, Werner Sieghart||, Priyanka Tiwari{ddagger}, John M. Lucocq**5, George Lees§, and Christopher L. Thompson{ddagger}{dagger}

From the {ddagger}Centre for Integrative Neurosciences, School of Biological and Biomedical Sciences, Science Research Laboratories, Durham University, South Road, Durham DH1 3LE, United Kingdom, the Centre for Brain Research, Medical University Vienna, Spitalgasse 4, Austria, ||Section for Biochemical Psychiatry, University Clinic for Psychiatry, A-1090 Vienna, Austria,**School of Life Sciences, University of Dundee, Dundee DD1 5EH, Scotland, United Kingdom, and the §Department of Pharmacology and Toxicology, Otago School of Medical Sciences, University of Otago, P. O. Box 56, Dunedin, New Zealand

Stargazer mice fail to express the {gamma}2 isoform of transmembrane {alpha}-amino-3-hydroxyl-5-methyl-4-isoxazolepropionate (AMPA) receptor regulatory proteins that has been shown to be absolutely required for the trafficking and synaptic targeting of excitatory AMPA receptors in adult murine cerebellar granule cells. Here we show that 30 ± 6% fewer inhibitory {gamma}-aminobutyric acid, type A (GABAA), receptors were expressed in adult stargazer cerebellum compared with controls because of a specific loss of GABAA receptor expression in the cerebellar granule cell layer. Radioligand binding assays allied to in situ immunogold-EM analysis and furosemide-sensitive tonic current estimates revealed that expression of the extrasynaptic ({alpha}6betax{delta}) {alpha}6-containing GABAA receptor were markedly and selectively reduced in stargazer. These observations were compatible with a marked reduction in expression of GABAA receptor {alpha}6, {delta} (mature cerebellar granule cell-specific proteins), and beta3 subunit expression in stargazer. The subunit composition of the residual {alpha}6-containing GABAA receptors was unaffected by the stargazer mutation. However, we did find evidence of an ~4-fold up-regulation of {alpha}1beta{delta} receptors that may compensate for the loss of {alpha}6-containing GABAA receptors. PCR analysis identified a dramatic reduction in the steady-state level of {alpha}6 mRNA, compatible with {alpha}6 being the primary target of the stargazer mutation-mediated GABAA receptor abnormalities. We propose that some aspects of assembly, trafficking, targeting, and/or expression of extrasynaptic {alpha}6-containing GABAA receptors in cerebellar granule cells are selectively regulated by AMPA receptor-mediated signaling.


Received for publication, January 4, 2007 , and in revised form, July 13, 2007.

* This work was supported in part by Grants 0543478 and 066204 (to C. L. T.) from the Wellcome Trust and Merck Sharp and Dohme Ltd. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement"in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Both authors contributed equally to this work.

3 Supported by an Otago Research Grant and the New Zealand Neurological Foundation.

4 Supported by the Austrian Science Fund Grant P17203 [GenBank] .

5 Supported by the Wellcome Trust, Research Leave Fellowship 059767/Z99/Z, and Tenovus, Scotland, UK.

{dagger} This paper is dedicated to the memory of Dr. Christopher L. Thompson, an accomplished neuroscientist, an inspirational colleague, and a valued friend, who died on June 5, 2007.

2 To whom correspondence should be addressed: School of Biological and Biomedical Sciences, Durham University, Science Research Laboratories, South Road, Durham, DH1 3LE, UK. Tel.: 44-191-334-1312; Fax: 44-191-334-1201; E-mail: H.L.Payne{at}durham.ac.uk.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement